search
Back to results

Nitrous Oxide for Lumbar Puncture (NO for LP)

Primary Purpose

Pain, Anxiety

Status
Unknown status
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Fixed 50:50 mixture of nitrous oxide and oxygen
Placebo
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring Spinal puncture, Pain, Anxiety, Nitrous oxyde

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients coming in the neurology department for a lumbar puncture
  • at least 18
  • no previous use of nitrous oxide

Exclusion Criteria:

  • contra-indication to nitrous oxide use
  • Body Mass Index>35
  • Mini Mental State Examination <24/30
  • Temperature >38°C
  • Confusion
  • Patient unable to communicate verbaly

Sites / Locations

  • CHU de Clermont-Ferrand

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Nitrous oxide

Placebo

Arm Description

will inhale experimental treatment (50% N2O - 50% O2)

will inhale medical air (22% O2 - 78% N2)

Outcomes

Primary Outcome Measures

Proportion of patients with significant pain
maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale

Secondary Outcome Measures

Proportion of patients with significant anxiety
maximal anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Analgesic efficacy measured with pain as a continuous variable
maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale
Anxiolytic efficacy measured with anxiety as a continuous variable
maximal anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Pain during the procedure evaluated one hour after the end of the lumbar puncture
maximal pain and anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Anxiety during the procedure evaluated one hour after the end of the lumbar puncture
maximal pain and anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Side effects
every side effects reported by the patients during the procedure up to 24 hours after the lumbar puncture, including post-puncture puncture headache
Impact of age on side effects
incidence and type of side effects according to patient age
Induced cost
supplementary cost induced by the use of nitrous oxide inhalation for a total of 81 patients throughout the study

Full Information

First Posted
July 19, 2017
Last Updated
July 21, 2017
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
University Hospital, Bordeaux, Hospices Civils de Lyon, Inserm U1107, NeuroDol, Université d'Auvergne
search

1. Study Identification

Unique Protocol Identification Number
NCT03228628
Brief Title
Nitrous Oxide for Lumbar Puncture
Acronym
NO for LP
Official Title
Impact of 50% Nitrous Oxide Inhalation on Pain and Anxiety Induced by Lumbar Puncture: a Multicenter Double-blind Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2017 (Anticipated)
Primary Completion Date
June 6, 2018 (Anticipated)
Study Completion Date
September 1, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
University Hospital, Bordeaux, Hospices Civils de Lyon, Inserm U1107, NeuroDol, Université d'Auvergne

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Lumbar puncture (LP) is a frequent exam that can cause pain and anxiety. In a pilot single-center study, it has been shown that nitrous oxide use during the procedure was able to reduce both pain and anxiety (Moisset et al., Eur J Neurol 2017). The goal of this multi-center trial is to confirm these results in a larger and more heterogeneous group of patients having a LP.
Detailed Description
Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century. Nonetheless, it's use during lumbar puncture in adults has only been investigated in a single-centre study. Thus, this study is designed to evaluate the analgesic effect of N2O on the pain induced during lumbar puncture. Patients with scheduled lumbar puncture realized for diagnosis purposes will be randomized in 2 groups. One group will inhale N2O for the 5 minutes before the puncture and during the rest of the procedure. The second group will inhale compressed air during the same period of time. Neither the investigator realizing the lumbar puncture, nor the patient will know which type of gaz they are inhaling (double-blinding). The maximal pain level that occurred during the procedure will be evaluated on a Numerical Rating Scale (NRS). NRS will also be used to evaluate the maximal anxiety induced by the procedure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Anxiety
Keywords
Spinal puncture, Pain, Anxiety, Nitrous oxyde

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
1:1 randomization to receive experimental treatment (50% N2O - 50% O2) or placebo (Medical Air: 22% O2 - 78% N2)
Masking
ParticipantOutcomes Assessor
Masking Description
double blinding. Gaz bottles are in undistinguishable boxes. Neither the patients nor the person doing the LP and the evaluation of pain and anxiety will know the treatment used
Allocation
Randomized
Enrollment
162 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Nitrous oxide
Arm Type
Experimental
Arm Description
will inhale experimental treatment (50% N2O - 50% O2)
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
will inhale medical air (22% O2 - 78% N2)
Intervention Type
Drug
Intervention Name(s)
Fixed 50:50 mixture of nitrous oxide and oxygen
Intervention Description
Gaz inhalation will start 5 minutes before the puncture and will be continued until the end of the procedure.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
inhale medical air (22% O2 - 78% N2)
Primary Outcome Measure Information:
Title
Proportion of patients with significant pain
Description
maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale
Time Frame
2-3 minutes after the end of gaz inhalation
Secondary Outcome Measure Information:
Title
Proportion of patients with significant anxiety
Description
maximal anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Time Frame
2-3 minutes after the end of gaz inhalation
Title
Analgesic efficacy measured with pain as a continuous variable
Description
maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale
Time Frame
2-3 minutes after the end of gaz inhalation.
Title
Anxiolytic efficacy measured with anxiety as a continuous variable
Description
maximal anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Time Frame
2-3 minutes after the end of gaz inhalation
Title
Pain during the procedure evaluated one hour after the end of the lumbar puncture
Description
maximal pain and anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Time Frame
1 hour after the end of gaz inhalation
Title
Anxiety during the procedure evaluated one hour after the end of the lumbar puncture
Description
maximal pain and anxiety perceived during the lumbar puncture evaluated using a simple numeric 0-10 scale
Time Frame
1 hour after the end of gaz inhalation
Title
Side effects
Description
every side effects reported by the patients during the procedure up to 24 hours after the lumbar puncture, including post-puncture puncture headache
Time Frame
from the beginning of gaz inhalation to 24 hours later
Title
Impact of age on side effects
Description
incidence and type of side effects according to patient age
Time Frame
during the procedure and the 24 hours after
Title
Induced cost
Description
supplementary cost induced by the use of nitrous oxide inhalation for a total of 81 patients throughout the study
Time Frame
at day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients coming in the neurology department for a lumbar puncture at least 18 no previous use of nitrous oxide Exclusion Criteria: contra-indication to nitrous oxide use Body Mass Index>35 Mini Mental State Examination <24/30 Temperature >38°C Confusion Patient unable to communicate verbaly
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xavier MOISSET, MD-PhD
Organizational Affiliation
CHU Clermont-Ferrand, Inserm, Neuro-Dol
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Clermont-Ferrand
City
Clermont-Ferrand
State/Province
Auvergne
ZIP/Postal Code
63003
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick LACARIN
Phone
04 73 75 11 95
Email
placarin@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Xavier MOISSET, MD-PhD
First Name & Middle Initial & Last Name & Degree
Sandra VUKUSIC, MD-PhD
First Name & Middle Initial & Last Name & Degree
Bruno BROCHET, MD-PhD
First Name & Middle Initial & Last Name & Degree
Pierre CLAVELOU, MD-PhD

12. IPD Sharing Statement

Learn more about this trial

Nitrous Oxide for Lumbar Puncture

We'll reach out to this number within 24 hrs